Join us at the 13th Injectables Summit 2023, a premier event dedicated to the rapidly evolving landscape of injectable devices for drug development. With the increasing prevalence of chronic diseases, the demand for sustainable solutions, and a heightened focus on patient centricity, it is crucial for industry professionals to stay informed about the latest developments and best practices in injectable device design and engineering.
This summit offers a unique opportunity to gain strategic insights and technical progress, enabling you to design and engineer high-quality devices that can reach the market quickly. With industry leaders such as Takeda, Sanofi, and Gilead providing a roadmap for accelerating innovation and integration, you will have access to valuable knowledge and expertise that can shape the future of injectable drug development.
The event will cover a wide range of topics, including the regulatory landscape, emerging technologies, design considerations, manufacturing processes, and safety and efficacy optimization. Engage with thought leaders, experts, and peers from pharmaceutical companies, medical device manufacturers, regulatory bodies, and academia to exchange ideas, explore collaborations, and stay ahead of the curve in this rapidly evolving field.
The recent approvals of groundbreaking products like Rykindo, UZEDY, and Brixadi, along with the successful launches of innovative injectable devices such as SCHOTT Pharma's prefillable polymer syringes for deep-cold drugs, highlight the immense interest and potential in the injectable drug-device space. By attending the 13th Injectables Summit, you will gain invaluable insights into the latest advancements, market trends, and future directions in this exciting field.
Don't miss this unparalleled opportunity to network, learn, and shape the future of injectable drug development. Join us at the 13th Injectables Summit 2023 and be at the forefront of innovation, driving the creation of injectable devices that optimize patient safety and efficacy while accelerating time-to-market.